Category Archives: Social Media

Sunset on the ROI of Social Media and Pharma Discussion

While many pharma companies have developed a wide and deep footprint in social media, many others have not.  When exploring the issue of whether or not to involve a brand, there are several questions to consider.  Some are very important … Continue reading

Posted in Social Media | 4 Comments

OPDP Issues Untitled Letter Involving Social Media

Sort of. There is, of course, a difference between a regulatory action letter that is issued because of a social media use and a regulatory action letter that is issued the communication happens to involve a social media platform.  In … Continue reading

Posted in Social Media, Warning Letters | 1 Comment

Looking Back Down the Road – What Have We Learned from FDA on Regulation of Digital Media?

So last week there was a lot of interest and commentary on the issuance of a draft guidance by FDA that provided some insight into how the agency is regulating promotional speech and social media platforms.  It seemed like a … Continue reading

Posted in FDA Policy, Social Media | 1 Comment

FDA Reveals More Thinking on Social Media

Don’t judge a book by its cover – or in this case, title. In November 2009, FDA held a two-day public meeting on the Promotion of FDA-Regulated Medical Products Using the Internet and Social Media to collect input for the … Continue reading

Posted in Social Media | 3 Comments

Abandoned Properties – Social Media and Pharma

Every so often, one sees an article about what happens to the social media identities of people who have passed away.  But what happens when a social media asset is abandoned – abandoned by a brand? Keeping track of social … Continue reading

Posted in Social Media | Comments Off